Thync

Alumni
Early Stage Venture


Digital Health

Website: www.thync.com
Total Funding: $13.00M
Funding Stage: Early Stage Venture

Developer of electronic wearable devices designed to offer treatments for autoimmune disorders and mental health. The company's non-invasive bio-electronic platform targets autonomic pathways important in a number of disease processes while providing superior safety relative to pharmaceutical interventions. The company's main focus is developing bio-electronic therapy in Psoriasis.
Skip to toolbar